Respiratorisches Synzytialvirus-Reference-Cited by-同舟云学术

Respiratorisches Synzytialvirus

Published:2019-09-05 Issue:11 Volume:60 Page:1146-1150
ISSN:0020-9554
Container-title:Der Internist
language:de
Short-container-title:Internist

Author:

Seidenberg Jürgen

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00108-019-00673-3.pdf

Reference27 articles.

1. Anderson EJ, DeVincenzo JP, Simoes EAS et al (2019) SENTINEL1: two-season study of respiratory syncytial virus hospitalizations among U.S. infants born at 29 to 35 weeks’gestanional age not receiving immunoprophylaxis. Am J Perinatol. https://doi.org/10.1055/s-0039-1681014 (epub ahead of print)

2. AWMF (2018) AWMF-Leitlinie: Prophylaxe von schweren Erkrankungen durch Respiratory Syncytial Virus (RSV) bei Risikokindern. https://www.awmf.org/leitlinien/detail/ll/048-012.html . Zugegriffen: 8. Juli 2019

3. Baglivo SJ, Polack FP (2019) The long road to protect infants against severe RSV lower respiratory tract illness. F1000Res 8:610. https://doi.org/10.12688/f1000research.18749.1

4. Blanken MO, Rovers MM, Molenaar JM et al (2013) Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 368(19):1791–1799

5. Bonville CA, Rosenberg HF, Domachowske JB (2006) Ribavirin and cysteinyl leukotriene‑1 rezeptor blockade as treatment for severe bronchiolitis. Antiviral Res 69(2):53–59

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated Network Pharmacology and Lipidomics to Reveal the Inhibitory Effect of Qingfei Oral Liquid on Excessive Autophagy in RSV-Induced Lung Inflammation;Frontiers in Pharmacology;2021-12-01

2. Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants;Frontiers in Pharmacology;2021-06-21